𝔖 Bobbio Scriptorium
✦   LIBER   ✦

GALANTAMINE IMPROVES GAIT PERFORMANCE IN PATIENTS WITH ALZHEIMER'S DISEASE

✍ Scribed by Frédéric Assal; Gilles Allali; Reto W. Kressig; François R. Herrmann; Olivier Beauchet

Book ID
109130009
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
58 KB
Volume
56
Category
Article
ISSN
0002-8614

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Galantamine: a randomized, double-blind,
Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease
✍ D. Wilkinson; J. Murray 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Abstract ## Objectives To investigate whether Galantamine significantly improves the core symptoms of Alzheimer's disease (AD). ## Background Galantamine is a reversible, competitive, selective inhibitor of acetylcholinesterase (AChE) that also allosterically modulates nicotinic acetylcholine

Treatment with galantamine and time to n
Treatment with galantamine and time to nursing home placement in Alzheimer's disease patients with and without cerebrovascular disease
✍ Howard H. Feldman; Tuula Pirttila; Jean François Dartigues; Brian Everitt; Bart 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB 👁 2 views

## Abstract ## Objective This study evaluated patient and treatment (galantamine and other acetylcholinesterase inhibitors (AChEIs)) factors associated with the time until nursing home placement (NHP) in patients with Alzheimer's disease (AD) with and without cerebrovascular disease (CVD). ## Met